MOREPENLAB₹123.54+4.99%
68/100
0100 · strongest
good
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %MOREPENLAB financial summary
For Mar 2026, Morepen Laboratories Ltd reported revenue of ₹1,681 crore, which grew 8.1% from the previous year. Net profit was ₹66 crore, which fell 35.3% year on year, on an operating margin of 7%. Earnings per share came in at ₹1.21. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹1,681 crore |
|---|---|
| Net profit | ₹66 crore |
| Operating margin | 7% |
| EPS | ₹1.21 |